Noshaq S.A., formerly known as Meusinvest, is a venture capital firm established in 1985 and based in Liège, Belgium. The firm specializes in seed, start-up, and growth capital investments in small and medium-sized enterprises, focusing on sectors such as energy, sustainable development, biotechnology, digital technologies, industry 4.0, real estate, quality food, and cultural industries. Noshaq typically invests in companies with annual revenues up to €50 million or an enterprise value up to €43 million, often taking a minority stake in these businesses. The firm may also request a seat on the Board of Directors as part of its investment strategy. In addition to equity investments, Noshaq provides financing solutions, including convertible bonds and loans, supporting strategic projects to stimulate economic development in the region.
ARK Capture Solutions is a cleantech company that specializes in providing affordable and versatile decarbonization services. It offers advanced carbon capture technology, designed to efficiently handle low CO₂ concentrations in flue gas, thereby enabling its clients to significantly reduce their carbon dioxide emissions while minimizing energy consumption.
Pleevi
Pre Seed Round in 2025
Pleevi specializes in optimizing electric vehicle (EV) charging for large parking facilities. It provides an AI-driven software solution that intelligently schedules charging sessions, considering local energy generation, pricing, and building load constraints. This ensures cheaper, greener charging while maintaining driver convenience, as vehicles are fully charged by the time drivers are ready to depart.
I-care
Series C in 2024
I-care Group is an industrial company based in Belgium, founded in 2004, that specializes in predictive and prescriptive maintenance services. The company utilizes artificial intelligence and data-driven solutions to enhance the collection and processing of industrial data, enabling clients to anticipate failures in machinery and equipment. By optimizing industrial risk management, I-care Group improves performance across business, human, and environmental dimensions. Its integrated technology expertise and asset management methods help decrease maintenance costs, increase equipment uptime, and enhance overall reliability and safety of operations. The company's focus on delivering high-quality service ensures that clients benefit from improved operational efficiency and effectiveness.
Signatur Biosciences
Signatur Biosciences, founded in 2022, focuses on advancing molecular diagnostics through an innovative PCR testing platform. This technology streamlines the detection and interpretation of RNA biomarkers into a single test, making precision diagnostics more accessible. The company's smart kit is designed to be compatible with existing clinical machines and off-the-shelf reagents, allowing clinicians to seamlessly integrate the testing process into their current workflows. By simplifying the diagnostic process, Signatur Biosciences aims to enhance the efficiency and effectiveness of clinical diagnostics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.